share_log

Both Individual Investors Who Control a Good Portion of 3SBio Inc. (HKG:1530) Along With Institutions Must Be Dismayed After Last Week's 3.8% Decrease

Both Individual Investors Who Control a Good Portion of 3SBio Inc. (HKG:1530) Along With Institutions Must Be Dismayed After Last Week's 3.8% Decrease

控制了三生製藥(HKG:1530)相當一部分股份的個人投資者和機構在上週3.8%的下跌後一定感到失望。
Simply Wall St ·  2024/12/19 14:18

Key Insights

關鍵洞察

  • 3SBio's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • The top 17 shareholders own 50% of the company
  • Institutional ownership in 3SBio is 28%
  • 三生製藥的重大個人投資者持股表明,關鍵決策受到更大公衆股東的影響。
  • 前17大股東擁有公司50%的股份。
  • 三生製藥的機構持股比例爲28%。

A look at the shareholders of 3SBio Inc. (HKG:1530) can tell us which group is most powerful. We can see that individual investors own the lion's share in the company with 42% ownership. Put another way, the group faces the maximum upside potential (or downside risk).

查看三生製藥股份有限公司(HKG:1530)的股東可以告訴我們哪個群體最強大。我們可以看到,個人投資者在公司中擁有42%的股份。換句話說,該群體面臨着最大的上行潛力(或下行風險)。

While the holdings of individual investors took a hit after last week's 3.8% price drop, institutions with their 28% holdings also suffered.

在上週價格下跌3.8%後,個人投資者的持股受到了影響,機構的28%持股也遭受了損失。

Let's take a closer look to see what the different types of shareholders can tell us about 3SBio.

讓我們更詳細地看看不同類型的股東能告訴我們關於三生製藥的信息。

big
SEHK:1530 Ownership Breakdown December 19th 2024
港交所:1530 股權分佈 2024年12月19日

What Does The Institutional Ownership Tell Us About 3SBio?

機構持股告訴我們關於三生製藥的什麼?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構的表現與近似當地市場的指數進行比較。因此,他們通常更加關注那些被納入主要指數的公司。

We can see that 3SBio does have institutional investors; and they hold a good portion of the company's stock. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see 3SBio's historic earnings and revenue below, but keep in mind there's always more to the story.

我們可以看到三生製藥確實有機構投資者,他們持有公司股票的一部分。這意味着爲這些機構工作的分析師已經關注了這隻股票,並且他們喜歡它。但就像其他任何人一樣,他們也可能是錯誤的。當多家機構持有某隻股票時,總是存在它們處於「擁擠交易」中的風險。當這種交易出現問題時,多方可能會競相快速賣出股票。這種風險在沒有增長曆史的公司中更高。您可以在下方看到三生製藥的歷史盈利和營業收入,但請記住,故事總是還有更多。

big
SEHK:1530 Earnings and Revenue Growth December 19th 2024
SEHK:1530 2024年12月19日的營業收入和營收增長

Hedge funds don't have many shares in 3SBio. Our data shows that Century Sunshine Limited is the largest shareholder with 20% of shares outstanding. With 8.3% and 3.0% of the shares outstanding respectively, BlackRock, Inc. and The Vanguard Group, Inc. are the second and third largest shareholders. Furthermore, CEO Jing Lou is the owner of 2.4% of the company's shares.

對沖基金在三生製藥中持有的股份不多。我們的數據顯示,世紀陽光有限公司是擁有20%流通股份的最大股東。貝萊德公司和先鋒集團公司分別持有8.3%和3.0%流通股份,是第二和第三大股東。此外,首席執行官劉靜持有公司2.4%的股份。

After doing some more digging, we found that the top 17 have the combined ownership of 50% in the company, suggesting that no single shareholder has significant control over the company.

經過進一步調查,我們發現前17名股東在公司中的合計持股比例爲50%,這表明沒有單一股東對公司擁有顯著控制權。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

研究機構的所有權是評估和篩選股票預期表現的好方法。分析師情緒的研究也可以達到同樣的效果。有很多分析師在覆蓋該股票,因此查看他們的預期可能也是值得的。

Insider Ownership Of 3SBio

三生製藥的內部持股

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

公司內部人士的定義可能是主觀的,並在不同法域之間有所不同。我們的數據顯示個人內部人士,至少捕獲了董事會成員。公司管理層對董事會負責,後者應代表股東的利益。值得注意的是,有時高層管理人員本身就是董事會成員。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

當內部持股顯示領導層像真正的公司所有者一樣思考時,這是積極的。然而,高比例的內部持股也可能給予公司內部小團體巨大的權力。在某些情況下,這可能是負面的。

Our most recent data indicates that insiders own some shares in 3SBio Inc.. This is a big company, so it is good to see this level of alignment. Insiders own HK$1.1b worth of shares (at current prices). If you would like to explore the question of insider alignment, you can click here to see if insiders have been buying or selling.

我們最新的數據表明,內部人員擁有三生製藥的一部分股份。這是一家大公司,因此看到這種程度的一致性是件好事。內部人員持有價值11億港元的股票(按當前價格計算)。如果您想探討內部人員一致性的問題,可以點擊這裏查看內部人員是否有買入或賣出的行爲。

General Public Ownership

公衆持股

The general public, who are usually individual investors, hold a 42% stake in 3SBio. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公衆,通常是個人投資者,持有三生製藥42%的股份。雖然這種持股規模可能不足以影響政策決策,但他們仍然可以對公司政策產生集體影響。

Private Company Ownership

私有公司所有權

We can see that Private Companies own 22%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

我們可以看到,私人公司擁有22%的已發行股份。可能值得對此進行深入研究。如果相關方,如內部人士,參與了這些私人公司的投資,則應在年度報告中披露。私人公司也可能對該公司有戰略利益。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand 3SBio better, we need to consider many other factors. For example, we've discovered 1 warning sign for 3SBio that you should be aware of before investing here.

考慮不同的股東在一家公司持有的股份總是值得的。但是,要更好地理解三生製藥,我們還需要考慮許多其他因素。 例如,我們發現三生製藥有一個警示信號,在您在此投資之前應該注意。

If you would prefer discover what analysts are predicting in terms of future growth, do not miss this free report on analyst forecasts.

如果您想了解分析師對未來增長的預測,請不要錯過這份關於分析師預測的免費報告。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論